Login
$DBVT
$10.27 -$0.75 (6.76%) Live

$DBVT SEC Filings

Filed On Filing
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13G/A
28 Oct 2026 8-K: Results of Operations and Financial Condition

Submitted the Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in children aged 4-7 Years and requested Priority Review

28 Oct 2026 10-Q
30 Sep 2026 8-K: Other Events

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

14 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 SCHEDULE 13G
31 Jul 2026 Form 4: Mohideen Pharis, Chief Medical Officer

Sold 464 shares ($1.25K)

27 Jul 2026 S-3ASR
16 Jul 2026 8-K: Results of Operations and Financial Condition

Continued productive engagement with the FDA in support of the BLA for the VIASKIN® Peanut Patch in children aged 4 through 7 years, with submission of the BLA anticipated in the third quarter of 2026

16 Jul 2026 10-Q
29 Jun 2026 8-K: Other Events

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

05 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

04 Jun 2026 S-8
03 Jun 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders

The Company was incorporated in the form of a French Limited Company (Société Anonyme) with a Board of Directors.

15 May 2026 SCHEDULE 13G/A
13 May 2026 SCHEDULE 13G/A
13 May 2026 SCHEDULE 13G/A
12 May 2026 SCHEDULE 13G/A
11 May 2026 ARS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support